Drugs / Photosan®
last change Dec 2011 re-read 3 minutes ago

Photosan®

Developed for
cholangiocarcinoma
Investigated by
Münchner Studienzentrum · Technical University of Munich

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00713687 Aug 2008 → Dec 2011 cholangiocarcinoma Technical University of Munich Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Photosan ClinicalTrials.gov intervention name — accepted as the source's own label NCT00713687 ↗
Route Intravenous “Photosan® 2 mg/kg i.v. 48 hrs before laser activation” NCT00713687 ↗